Eutilex.Co.,Ltd (KOSDAQ:263050)
South Korea · Delayed Price · Currency is KRW 959.00
+221.00 (29.95%)
At close: Feb 6, 2026
Eutilex.Co.,Ltd Market Cap
Eutilex.Co.,Ltd has a market cap or net worth of 35.32 billion as of February 20, 2026. Its market cap has decreased by -52.87% in one year.
Market Cap
35.32B
Enterprise Value
45.79B
Revenue
10.54B
Ranking
n/a
PE Ratio
n/a
Stock Price
959.00
Market Cap Chart
Since December 24, 2018, Eutilex.Co.,Ltd's market cap has decreased from 567.29B to 35.32B, a decrease of -93.77%. That is a compound annual growth rate of -32.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 35.32B | -13.45% |
| Dec 30, 2025 | 40.81B | -42.41% |
| Dec 30, 2024 | 70.86B | -42.97% |
| Dec 28, 2023 | 124.25B | -49.10% |
| Dec 29, 2022 | 244.11B | -29.44% |
| Dec 30, 2021 | 345.97B | -38.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyeGene | 56.67B |
| NGeneBio | 54.39B |
| J2KBIO | 49.94B |
| Aptamer Sciences | 47.95B |
| SCM Lifescience | 38.90B |
| Kainos Medicine | 35.56B |
| Epibiotech | 34.03B |
| MOA Life Plus | 32.89B |